FLOREY: An eHealth antimicrobial stewardship tool demonstrated for RTIs

FLOREY是一种电子健康/移动健康抗菌（AM）管理工具，为呼吸道感染（RTI）的抗生素处方提供了新的替代方案。当抗生素不适用时，FLOREY将支持患者自我护理，满足患者对积极治疗方法的期望，同时为患者和医生提供安全网。它将为医疗保健系统提供一系列直接成本节约（减少处方和不必要的预约成本）和间接成本节约（减少治疗耐药感染的支出）。FLOREY由AccuRx和南安普顿大学开发，将由2个主要平台组成：从业者侧软件包和患者侧SMS消息界面。机器学习和大数据分析将自动分析患者的症状进展，并根据选定的逻辑路径提供输出。它将使从业者获得数据驱动的诊断，而不是目前的经验技术，用信息快照、重大回忆偏差和结果不可见来做出诊断。最终，弗洛里将减少AM处方的数量。这将对整个医疗保健行业非常有益，提高了当前AM药物和正在开发的药物的寿命。

FLOREY, is an eHealth/mHealth antimicrobial (AM) stewardship tool which offers a new alternative to antibiotic prescribing for respiratory tract infections (RTIs). When an antibiotic is not indicated, FLOREY will support patient self-care, satisfying the patient’s expectation for an active treatment approach whilst also providing a safety net for both the patient and practitioner. It will provide a range of direct cost savings (reduced cost of prescriptions and unnecessary appointments) and indirect cost savings (reduced spend on treating drug-resistant infections) to the healthcare system. FLOREY, developed by AccuRx and the University of Southampton, will consist of 2 main platforms: a practitioner side software package, and patient side SMS message interface. Machine learning and big data analysis will automatically analyse patients' symptomatic progression and offer outputs based on a chosen logic pathway. lt will give a practitioner access to a data-driven diagnosis, rather than current empirical techniques, made with a snapshot of information, significant recall bias and no visibility of outcomes. Ultimately, FLOREY will reduce the number of AM prescriptions. This will be highly beneficial to the entire healthcare industry, improving the lifespan of current AM drugs and those in development.